VOYA Investment Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,687
Closed -$617K 2790
2020
Q4
$617K Buy
+4,687
New +$414K ﹤0.01% 1783
2020
Q2
Sell
-5,699
Closed -$279K 2689
2020
Q1
$279K Buy
5,699
+283
+5% +$14.4K ﹤0.01% 1955
2019
Q4
$311K Buy
+5,416
New +$268K ﹤0.01% 2162

VOYA Investment Management's EIDX Position: Q1 2021 in Review

VOYA Investment Management sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 4,687 shares — an estimated $617K sold.

VOYA Investment Management first reported a position in EIDX in Q4 2019 and held it in 3 quarters. The position peaked at $617K in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • VOYA Investment Management reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • VOYA Investment Management sold 4,687 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $617K.
  • VOYA Investment Management first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
  • VOYA Investment Management's Eidos Therapeutics, Inc. Common Stock position peaked at $617K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on VOYA Investment Management's 13F filing for Q1 2021, filed 17 May 2021.